Medtronic wins FDA clearance for Stealth AXiS robot in cranial, ENT procedures
March 27, 2026
Medtronic (NYSE:MDT) announced today that the FDA cleared its Stealth AXiS surgical robotic system for new indications.
Medtronic (NYSE:MDT) announced today that the FDA cleared its Stealth AXiS surgical robotic system for new indications.
Novo Nordisk announced today that it received FDA approval for Awiqli, the first and only once-weekly, long-acting basal insulin.
https://www.discovermagazine.com/over-20-years-one-mouse-was-cloned-for-58-generations-until-the-line-collapsed-48884
The system uses AI to optimize the placement of Edwards’ mitral valve repair device.
“It is one of the few treatments that specifically targets movement-evoked pain and fatigue, which are major barriers to participation in daily activities,” says Sluka, UI professor of physical therapy and rehabilitation science.
Scientists at the University of Utah (the U) have developed a new “lab-on-a-chip” device that uses artificial intelligence to rapidly predict cancer cell sensitivity to targeted therapies for children with T-cell acute lymphoblastic leukemia (T-ALL), an aggressive and difficult-to-treat cancer.